XML 46 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
Legal Proceedings, Commitments and Contingencies Details (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Jul. 06, 2016
Jul. 01, 2016
Jun. 24, 2016
Jul. 31, 2016
Jun. 30, 2016
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Loss Contingencies [Line Items]                    
Payable by the insurance carriers               $ 21,700    
Total settlements           $ 1,800 $ 0 1,800 $ 0 $ (26,800)
Galena Biopharma, Inc. Derivative Litigation, Civil Action No. 3:14-cv-00382-SI [Member]                    
Loss Contingencies [Line Items]                    
Total settlements               5,000    
Galena Biopharma, Inc. Securities Litigation, Civil Action No. 3:14-cv-00367-SI [Member]                    
Loss Contingencies [Line Items]                    
Total settlements               20,000    
Payments for legal settlements, paid by insurance               $ 21,700    
Scenario, Forecast [Member]                    
Loss Contingencies [Line Items]                    
Payable by the company in cash (paid in July 2016)         $ 2,450          
Settled Litigation [Member] | Galena Biopharma, Inc. Derivative Litigation, Civil Action No. 3:14-cv-00382-SI [Member]                    
Loss Contingencies [Line Items]                    
Legal fees     $ 4,500              
Payable by the insurance carriers     $ 15,000              
Stock option cancellation in period (in shares)     1,200,000              
Settled Litigation [Member] | Galena Biopharma, Inc. Securities Litigation, Civil Action No. 3:14-cv-00367-SI [Member]                    
Loss Contingencies [Line Items]                    
Legal fees     $ 4,500              
Total settlements     $ 20,000              
Settled Litigation [Member] | Securities Litigation, Opt Out Settlement, Case 1 [Member]                    
Loss Contingencies [Line Items]                    
Total settlements       $ 150            
Litigation settlement, issuance of common stock, value       $ 150            
Litigation settlement, issuance of common stock (in shares)       291,262            
Settled Litigation [Member] | Securities Litigation, Opt Out Settlement, Case 2 [Member]                    
Loss Contingencies [Line Items]                    
Litigation settlement, issuance of common stock, value       $ 1,500            
Litigation settlement, issuance of common stock (in shares)       3,366,750            
Settled Litigation [Member] | Subsequent Event [Member] | Galena Biopharma, Inc. Securities Litigation, Civil Action No. 3:14-cv-00367-SI [Member]                    
Loss Contingencies [Line Items]                    
Payments for legal settlements, paid by insurance   $ 16,700                
Payable by the company in cash (paid in July 2016)   $ 2,300                
Litigation settlement, issuance of common stock, value $ 1,000       $ 1,000          
Litigation settlement, issuance of common stock (in shares) 480,053